This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keeley, E. C. Articles by Safian, R. D. Search for Related Content PubMed PubMed Citation Articles by Keeley, E. C. Articles by Safian, R. D.

Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts

^a Department of Internal Medicine (Cardiovascular Division), William Beaumont Hospital, Royal Oak, Michigan, USA

View larger version (14K): [in a new window]   Figure 1 Univariate predictors for (A) in-hospital and (B) late major adverse cardiac events (MACE). CHF = congestive heart failure; IABP = intra-aortic balloon pump; MI = myocardial infarction; PVD = peripheral vascular disease; USA = unstable angina.

View larger version (12K): [in a new window]   Figure 2 Total and event-free survival for patients after percutaneous revascularization of saphenous vein grafts. Solid diamond = death; solid square = death, MI; solid triangle = death, MI, repeat CABG; solid circle = death, MI, any target vessel revascularization. CABG = coronary artery bypass graft surgery; MI = myocardial infarction.

View larger version (9K): [in a new window]   Figure 3 Freedom from repeat target vessel revascularization (percutaneous and surgical revascularization) after saphenous vein graft intervention. Solid diamond = stent (n = 415); solid square = no stent (n = 614). p = 0.4.

View larger version (9K): [in a new window]   Figure 4 Freedom from death, myocardial infarction, percutaneous revascularization or redo-bypass surgery after saphenous vein graft intervention. Solid diamond = stent (n = 415); solid square = no stent (n = 614). p = 0.2.